Zevra Therapeutics Stock Forecast

Buy or Hold candidate since Jun 08, 2026 Gain 11.83%

The Zevra Therapeutics, Inc. stock price gained 2.19% on the last trading day (Friday, 26th Jun 2026), rising from $13.23 to $13.52. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.73% from a day low at $13.20 to a day high of $13.83. The price has risen in 6 of the last 10 days and is up by 4.24% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 0 shares were bought and sold for approximately $0 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.06% during the next 3 months and, with a 90% probability hold a price between $15.42 and $19.43 at the end of this 3-month period.

ZVRA Signals & Forecast

The Zevra Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.00 and $11.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 6.88%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Zevra Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.65 and $12.09. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zevra Therapeutics, Inc. finds support just below today's level at $12.65. If this is broken, then the next support from accumulated volume will be at $12.09 and $11.40.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.625 between high and low, or 4.73%. For the last week the stock has had daily average volatility of 4.20%

Our recommended stop-loss: $13.11 (-3.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (ZVRA) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Zevra Therapeutics, Inc. to open at $13.52, and during the day (based on 14 day Average True Range), to move between $13.19 and $13.85, which gives a possible trading interval of +/-$0.656 (+/-4.97%) up or down from last closing price. If Zevra Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.66 (1.04%) than the support at $12.65 (6.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Zevra Therapeutics, Inc. stock A Buy?

Zevra Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 5.792 Strong Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $13.52 ( 0.0370%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk